On the stock market since 2013, it operates in the world of health and science. It has 991 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 34% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $1.5B would still be left in the vault — a solid cushion for hard times.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
Clearly below the class average.
Sales are growing strongly for its sector.
Clearly above the class average — a step short of the very top.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Executive Buying: The trades send no strong signal of confidence.
The stock trades below its recent peak — about 12% off the top. A pullback, not a collapse.
The net profit margin is 39% — that slice of every sale is the company’s cushion in hard quarters.
Over the last 3 years, sales grew about 35% a year on average.
There is $1.9B in the vault; even if every debt were paid off, $1.5B would remain.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 41/100.
Today’s price already includes part of tomorrow’s optimism. Report-card grade: 48/100.
No clear buy-side message is coming from the executive floor. Council score: 3/10.
On our five-subject report card, PTCT sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: PTCT is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Analysts’ average target sits above today’s price, yet the valuation grade (48/100) says the stock isn’t cheap.